N-[(3S,6R)-6-(1,3-benzothiazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;(2S)-N'-tert-butyl-N-[1-(7-fluoro-3H-indol-2-yl)cyclopropyl]-2-[(4-methylphenyl)sulfonylmethyl]butanediamide;5,5,5-trifluoro-N-[(3S,6R)-6-(1-methylbenzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]pentanamide

C147H166F12N16O18S2 — CID 162165681

IUPACN-[(3S,6R)-6-(1,3-benzothiazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;(2S)-N'-tert-butyl-N-[1-(7-fluoro-3H-indol-2-yl)cyclopropyl]-2-[(4-methylphenyl)sulfonylmethyl]butanediamide;5,5,5-trifluoro-N-[(3S,6R)-6-(1-methylbenzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]pentanamide
SMILESC[C@H](CC(=O)[C@H](CC(=O)N1CCC[C@@H]1c1ccccc1)NC(=O)C1CC2(C1)CC(F)(F)C2)c1nc2ccccc2o1.C[C@H](CC(=O)[C@H](CC(=O)N1CCC[C@@H]1c1ccccc1)NC(=O)CCCC(F)(F)F)c1nc2ccccc2n1C.C[C@H](CC(=O)[C@H](CC(=O)N1CCC[C@@H]1c1ccccc1)NC(=O)CCCC(F)(F)F)c1nc2ccccc2o1.C[C@H](CC(=O)[C@H](CC(=O)N1CCC[C@@H]1c1ccccc1)NC(=O)CCCC(F)(F)F)c1nc2ccccc2s1.Cc1ccc(S(=O)(=O)C[C@@H](CC(=O)NC(C)(C)C)C(=O)NC2(C3=Nc4c(F)cccc4C3)CC2)cc1
InChIInChI=1S/C32H35F2N3O4.C30H35F3N4O3.C29H32F3N3O4.C29H32F3N3O3S.C27H32FN3O4S/c1-20(30-36-23-10-5-6-12-27(23)41-30)14-26(38)24(35-29(40)22-16-31(17-22)18-32(33,34)19-31)15-28(39)37-13-7-11-25(37)21-8-3-2-4-9-21;1-20(29-35-22-12-6-7-13-25(22)36(29)2)18-26(38)23(34-27(39)15-8-16-30(31,32)33)19-28(40)37-17-9-14-24(37)21-10-4-3-5-11-21;2*1-19(28-34-21-11-5-6-13-25(21)39-28)17-24(36)22(33-26(37)14-7-15-29(30,31)32)18-27(38)35-16-8-12-23(35)20-9-3-2-4-10-20;1-17-8-10-20(11-9-17)36(34,35)16-19(15-23(32)30-26(2,3)4)25(33)31-27(12-13-27)22-14-18-6-5-7-21(28)24(18)29-22/h2-6,8-10,12,20,22,24-25H,7,11,13-19H2,1H3,(H,35,40);3-7,10-13,20,23-24H,8-9,14-19H2,1-2H3,(H,34,39);2*2-6,9-11,13,19,22-23H,7-8,12,14-18H2,1H3,(H,33,37);5-11,19H,12-16H2,1-4H3,(H,30,32)(H,31,33)/t20-,24+,25-;20-,23+,24-;2*19-,22+,23-;19-/m11111/s1
InChIKeyZNCBRHMPHLMKNN-YDAVFSNESA-N
MW2737.15 g/mol
LogP27.56
Rot. Bonds50

About N-[(3S,6R)-6-(1,3-benzothiazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;(2S)-N'-tert-butyl-N-[1-(7-fluoro-3H-indol-2-yl)cyclopropyl]-2-[(4-methylphenyl)sulfonylmethyl]butanediamide;5,5,5-trifluoro-N-[(3S,6R)-6-(1-methylbenzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]pentanamide

N-[(3S,6R)-6-(1,3-benzothiazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;(2S)-N'-tert-butyl-N-[1-(7-fluoro-3H-indol-2-yl)cyclopropyl]-2-[(4-methylphenyl)sulfonylmethyl]butanediamide;5,5,5-trifluoro-N-[(3S,6R)-6-(1-methylbenzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]pentanamide (PubChem CID 162165681) has the molecular formula C147H166F12N16O18S2 and a molecular weight of 2737.15 g/mol. Its IUPAC name is N-[(3S,6R)-6-(1,3-benzothiazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;(2S)-N'-tert-butyl-N-[1-(7-fluoro-3H-indol-2-yl)cyclopropyl]-2-[(4-methylphenyl)sulfonylmethyl]butanediamide;5,5,5-trifluoro-N-[(3S,6R)-6-(1-methylbenzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]pentanamide.

Molecular Properties

Compound NameN-[(3S,6R)-6-(1,3-benzothiazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;(2S)-N'-tert-butyl-N-[1-(7-fluoro-3H-indol-2-yl)cyclopropyl]-2-[(4-methylphenyl)sulfonylmethyl]butanediamide;5,5,5-trifluoro-N-[(3S,6R)-6-(1-methylbenzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]pentanamide
PubChem CID162165681
Molecular FormulaC147H166F12N16O18S2
Molecular Weight2737.15 g/mol
Exact Mass2735.18
IUPAC NameN-[(3S,6R)-6-(1,3-benzothiazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;(2S)-N'-tert-butyl-N-[1-(7-fluoro-3H-indol-2-yl)cyclopropyl]-2-[(4-methylphenyl)sulfonylmethyl]butanediamide;5,5,5-trifluoro-N-[(3S,6R)-6-(1-methylbenzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]pentanamide
SMILESC[C@H](CC(=O)[C@H](CC(=O)N1CCC[C@@H]1c1ccccc1)NC(=O)C1CC2(C1)CC(F)(F)C2)c1nc2ccccc2o1.C[C@H](CC(=O)[C@H](CC(=O)N1CCC[C@@H]1c1ccccc1)NC(=O)CCCC(F)(F)F)c1nc2ccccc2n1C.C[C@H](CC(=O)[C@H](CC(=O)N1CCC[C@@H]1c1ccccc1)NC(=O)CCCC(F)(F)F)c1nc2ccccc2o1.C[C@H](CC(=O)[C@H](CC(=O)N1CCC[C@@H]1c1ccccc1)NC(=O)CCCC(F)(F)F)c1nc2ccccc2s1.Cc1ccc(S(=O)(=O)C[C@@H](CC(=O)NC(C)(C)C)C(=O)NC2(C3=Nc4c(F)cccc4C3)CC2)cc1
InChIInChI=1S/C32H35F2N3O4.C30H35F3N4O3.C29H32F3N3O4.C29H32F3N3O3S.C27H32FN3O4S/c1-20(30-36-23-10-5-6-12-27(23)41-30)14-26(38)24(35-29(40)22-16-31(17-22)18-32(33,34)19-31)15-28(39)37-13-7-11-25(37)21-8-3-2-4-9-21;1-20(29-35-22-12-6-7-13-25(22)36(29)2)18-26(38)23(34-27(39)15-8-16-30(31,32)33)19-28(40)37-17-9-14-24(37)21-10-4-3-5-11-21;2*1-19(28-34-21-11-5-6-13-25(21)39-28)17-24(36)22(33-26(37)14-7-15-29(30,31)32)18-27(38)35-16-8-12-23(35)20-9-3-2-4-10-20;1-17-8-10-20(11-9-17)36(34,35)16-19(15-23(32)30-26(2,3)4)25(33)31-27(12-13-27)22-14-18-6-5-7-21(28)24(18)29-22/h2-6,8-10,12,20,22,24-25H,7,11,13-19H2,1H3,(H,35,40);3-7,10-13,20,23-24H,8-9,14-19H2,1-2H3,(H,34,39);2*2-6,9-11,13,19,22-23H,7-8,12,14-18H2,1H3,(H,33,37);5-11,19H,12-16H2,1-4H3,(H,30,32)(H,31,33)/t20-,24+,25-;20-,23+,24-;2*19-,22+,23-;19-/m11111/s1
InChIKeyZNCBRHMPHLMKNN-YDAVFSNESA-N
XLogP27.56
TPSA453.39 Ų
H-Bond Donors6
H-Bond Acceptors25
Rotatable Bonds50
Heavy Atoms195
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002737.15
LogP ≤ 527.56
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1025

Analyze N-[(3S,6R)-6-(1,3-benzothiazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;(2S)-N'-tert-butyl-N-[1-(7-fluoro-3H-indol-2-yl)cyclopropyl]-2-[(4-methylphenyl)sulfonylmethyl]butanediamide;5,5,5-trifluoro-N-[(3S,6R)-6-(1-methylbenzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]pentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(3S,6R)-6-(1,3-benzothiazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;(2S)-N'-tert-butyl-N-[1-(7-fluoro-3H-indol-2-yl)cyclopropyl]-2-[(4-methylphenyl)sulfonylmethyl]butanediamide;5,5,5-trifluoro-N-[(3S,6R)-6-(1-methylbenzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]pentanamide?
The IUPAC name of N-[(3S,6R)-6-(1,3-benzothiazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;(2S)-N'-tert-butyl-N-[1-(7-fluoro-3H-indol-2-yl)cyclopropyl]-2-[(4-methylphenyl)sulfonylmethyl]butanediamide;5,5,5-trifluoro-N-[(3S,6R)-6-(1-methylbenzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]pentanamide (CID 162165681) is N-[(3S,6R)-6-(1,3-benzothiazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;(2S)-N'-tert-butyl-N-[1-(7-fluoro-3H-indol-2-yl)cyclopropyl]-2-[(4-methylphenyl)sulfonylmethyl]butanediamide;5,5,5-trifluoro-N-[(3S,6R)-6-(1-methylbenzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]pentanamide.
What is the SMILES notation for N-[(3S,6R)-6-(1,3-benzothiazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;(2S)-N'-tert-butyl-N-[1-(7-fluoro-3H-indol-2-yl)cyclopropyl]-2-[(4-methylphenyl)sulfonylmethyl]butanediamide;5,5,5-trifluoro-N-[(3S,6R)-6-(1-methylbenzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]pentanamide?
The canonical SMILES for N-[(3S,6R)-6-(1,3-benzothiazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;(2S)-N'-tert-butyl-N-[1-(7-fluoro-3H-indol-2-yl)cyclopropyl]-2-[(4-methylphenyl)sulfonylmethyl]butanediamide;5,5,5-trifluoro-N-[(3S,6R)-6-(1-methylbenzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]pentanamide is C[C@H](CC(=O)[C@H](CC(=O)N1CCC[C@@H]1c1ccccc1)NC(=O)C1CC2(C1)CC(F)(F)C2)c1nc2ccccc2o1.C[C@H](CC(=O)[C@H](CC(=O)N1CCC[C@@H]1c1ccccc1)NC(=O)CCCC(F)(F)F)c1nc2ccccc2n1C.C[C@H](CC(=O)[C@H](CC(=O)N1CCC[C@@H]1c1ccccc1)NC(=O)CCCC(F)(F)F)c1nc2ccccc2o1.C[C@H](CC(=O)[C@H](CC(=O)N1CCC[C@@H]1c1ccccc1)NC(=O)CCCC(F)(F)F)c1nc2ccccc2s1.Cc1ccc(S(=O)(=O)C[C@@H](CC(=O)NC(C)(C)C)C(=O)NC2(C3=Nc4c(F)cccc4C3)CC2)cc1.
What is the InChIKey of N-[(3S,6R)-6-(1,3-benzothiazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;(2S)-N'-tert-butyl-N-[1-(7-fluoro-3H-indol-2-yl)cyclopropyl]-2-[(4-methylphenyl)sulfonylmethyl]butanediamide;5,5,5-trifluoro-N-[(3S,6R)-6-(1-methylbenzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]pentanamide?
The InChIKey is ZNCBRHMPHLMKNN-YDAVFSNESA-N. The full InChI is InChI=1S/C32H35F2N3O4.C30H35F3N4O3.C29H32F3N3O4.C29H32F3N3O3S.C27H32FN3O4S/c1-20(30-36-23-10-5-6-12-27(23)41-30)14-26(38)24(35-29(40)22-16-31(17-22)18-32(33,34)19-31)15-28(39)37-13-7-11-25(37)21-8-3-2-4-9-21;1-20(29-35-22-12-6-7-13-25(22)36(29)2)18-26(38)23(34-27(39)15-8-16-30(31,32)33)19-28(40)37-17-9-14-24(37)21-10-4-3-5-11-21;2*1-19(28-34-21-11-5-6-13-25(21)39-28)17-24(36)22(33-26(37)14-7-15-29(30,31)32)18-27(38)35-16-8-12-23(35)20-9-3-2-4-10-20;1-17-8-10-20(11-9-17)36(34,35)16-19(15-23(32)30-26(2,3)4)25(33)31-27(12-13-27)22-14-18-6-5-7-21(28)24(18)29-22/h2-6,8-10,12,20,22,24-25H,7,11,13-19H2,1H3,(H,35,40);3-7,10-13,20,23-24H,8-9,14-19H2,1-2H3,(H,34,39);2*2-6,9-11,13,19,22-23H,7-8,12,14-18H2,1H3,(H,33,37);5-11,19H,12-16H2,1-4H3,(H,30,32)(H,31,33)/t20-,24+,25-;20-,23+,24-;2*19-,22+,23-;19-/m11111/s1.
What are the key properties of N-[(3S,6R)-6-(1,3-benzothiazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;(2S)-N'-tert-butyl-N-[1-(7-fluoro-3H-indol-2-yl)cyclopropyl]-2-[(4-methylphenyl)sulfonylmethyl]butanediamide;5,5,5-trifluoro-N-[(3S,6R)-6-(1-methylbenzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]pentanamide?
N-[(3S,6R)-6-(1,3-benzothiazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;(2S)-N'-tert-butyl-N-[1-(7-fluoro-3H-indol-2-yl)cyclopropyl]-2-[(4-methylphenyl)sulfonylmethyl]butanediamide;5,5,5-trifluoro-N-[(3S,6R)-6-(1-methylbenzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]pentanamide has a molecular weight of 2737.15 g/mol, XLogP of 27.56, 50 rotatable bonds, 6 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3S,6R)-6-(1,3-benzothiazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-2,2-difluorospiro[3.3]heptane-6-carboxamide;N-[(3S,6R)-6-(1,3-benzoxazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]-5,5,5-trifluoropentanamide;(2S)-N'-tert-butyl-N-[1-(7-fluoro-3H-indol-2-yl)cyclopropyl]-2-[(4-methylphenyl)sulfonylmethyl]butanediamide;5,5,5-trifluoro-N-[(3S,6R)-6-(1-methylbenzimidazol-2-yl)-1,4-dioxo-1-[(2R)-2-phenylpyrrolidin-1-yl]heptan-3-yl]pentanamide is sourced from PubChem (CID 162165681), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).